Filing Details
- Accession Number:
- 0001562180-20-006379
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 19:22:28
- Reporting Period:
- 2020-10-15
- Accepted Time:
- 2020-10-16 19:22:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636422 | Health Catalyst Inc. | HCAT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494174 | H. Daniel Orenstein | C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-15 | 5,000 | $10.34 | 45,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-15 | 3,733 | $35.14 | 41,267 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-15 | 1,267 | $35.63 | 40,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-15 | 5,000 | $0.00 | 5,000 | $10.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,816 | 2019-12-31 | 2026-02-10 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.
- Represents the weighted average sale price of the shares sold ranging from $34.53 to $35.52 per share, inclusive.
- Represents the weighted average sale price of the shares sold ranging from $35.53 to $35.77 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3).
- 25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019.
Billionaire Hedge Funds
